Stockreport

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Revenues of US$24m beat estimates by a substantial 32% margin. Unfortunately, Nektar Therapeutics also reported a statutory loss of US$0.18 per share, which at least was [Read more]